4/A//SEC Filing
Valeant Pharmaceuticals International, Inc. 4/A
Accession 0000885590-13-000031
$BHCCIK 0000885590operating
Filed
May 27, 8:00 PM ET
Accepted
May 28, 7:16 PM ET
Size
5.2 KB
Accession
0000885590-13-000031
Insider Transaction Report
Form 4/AAmended
POWER ROBERT N
Director
Transactions
- Award
Common Shares, no par value
2013-05-24+5,022→ 17,481 total
Footnotes (2)
- [F1]Regular annual grant of restricted stock units equal to $375,000 divided by the closing price of registrant common stock on the date prior to grant, which is the third trading day following the annual meeting.
- [F2]This number represents common shares purchased and other equity awards that were previously reported in Table 1.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4/A
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 7:16 PM ET
- Size
- 5.2 KB